CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,658,000	$ 2,178,000
Other current assets	47,000	65,000
Total current assets	1,705,000	2,243,000
Other assets:
Due from related parties	965,000	930,000
Investments in unconsolidated entities	146,000	141,000
Goodwill	315,000	315,000
Total other assets	1,426,000	1,386,000
Property and equipment:
Operating lease right-of-use asset	49,000	59,000
Total property and equipment	49,000	59,000
TOTAL ASSETS	3,180,000	3,688,000
Current liabilities:
Operating lease right-of-use liability - current portion	44,000	43,000
Accounts payable and accrued expenses	177,000	170,000
Income taxes payable	403,000	114,000
Total current liabilities	624,000	327,000
Operating lease right-of-use liability - net of current portion	12,000	23,000
Guarantee liability	11,000	11,000
Total liabilities	647,000	361,000
EQUITY
Common stock - par value $.01; 25,000,000 shares authorized; 7,792,185 shares issued and outstanding at March 31, 2022 and December 31, 2021.	78,000	78,000
Additional paid-in capital	2,871,000	2,871,000
Accumulated deficit	(794,000)	(119,000)
U.S. Neurosurgical Holdings, Inc. stockholders' equity	2,155,000	2,830,000
Noncontrolling interests	378,000	497,000
Total equity	2,533,000	3,327,000
TOTAL LIABILITIES AND EQUITY	$ 3,180,000	$ 3,688,000